Ernexa Therapeutics, Inc. (ERNA)
2.05
+0.17
(+9.04%)
USD |
NASDAQ |
Nov 09, 16:00
Ernexa Therapeutics Cash and Short Term Investments (Quarterly) : 5.575M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.575M |
| June 30, 2026 | 5.028M |
| March 31, 2026 | 9.177M |
| December 31, 2025 | 1.884M |
| September 30, 2025 | 3.047M |
| June 30, 2025 | 4.315M |
| March 31, 2025 | 1.918M |
| December 31, 2024 | 1.729M |
| September 30, 2024 | 4.264M |
| June 30, 2024 | 2.586M |
| March 31, 2024 | 5.116M |
| December 31, 2023 | 7.575M |
| September 30, 2023 | 4.551M |
| June 30, 2023 | 1.837M |
| March 31, 2023 | 5.397M |
| December 31, 2022 | 11.45M |
| September 30, 2022 | 13.25M |
| June 30, 2022 | 19.41M |
| March 31, 2022 | 23.50M |
| December 31, 2021 | 16.98M |
| September 30, 2021 | 24.38M |
| June 30, 2021 | 50.16M |
| March 31, 2021 | 8.410M |
| December 31, 2020 | 1.63M |
| September 30, 2020 | 1.71M |
| Date | Value |
|---|---|
| June 30, 2020 | 2.435M |
| March 31, 2020 | 2.271M |
| December 31, 2019 | 3.259M |
| September 30, 2019 | 2.584M |
| June 30, 2019 | 2.778M |
| March 31, 2019 | 2.716M |
| December 31, 2018 | 2.586M |
| September 30, 2018 | 3.078M |
| June 30, 2018 | 3.785M |
| March 31, 2018 | 2.635M |
| December 31, 2017 | 3.378M |
| September 30, 2017 | 4.464M |
| June 30, 2017 | 6.834M |
| March 31, 2017 | 6.113M |
| December 31, 2016 | 5.686M |
| September 30, 2016 | 3.016M |
| June 30, 2016 | 3.571M |
| March 31, 2016 | 3.549M |
| December 31, 2015 | 3.223M |
| September 30, 2015 | 4.678M |
| June 30, 2015 | 5.391M |
| March 31, 2015 | 7.163M |
| December 31, 2014 | 7.185M |
| September 30, 2014 | 9.84M |
| June 30, 2014 | 11.16M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cerenome, Inc. | 8.587M |
| ACADIA Pharmaceuticals, Inc. | 976.45M |
| Alnylam Pharmaceuticals, Inc. | 3.587B |
| Anika Therapeutics, Inc. | 44.96M |
| Savara, Inc. | 173.03M |